Status | Study |
Recruiting |
Study Name: Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche Condition: Graft-vs-Host Disease Date: 2012-01-11 |
Terminated |
Study Name: Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients Condition: Graft vs Host Disease Date: 2011-01-23 Interventions: Drug: Itraconazole 200mg bid, oral solution, until a dose of prednisone was tapered to 10mg/day in case |
Completed |
Study Name: Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation Condition: Graft vs Host Disease Date: 2010-08-02 Interventions: Drug: Atorvastatin calcium (Lipitor) 40 mg PO daily |
Completed |
Study Name: Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) Condition: Graft vs Host Disease Date: 2010-05-05 Interventions: Genetic: Mesenchymal stromal cells Mesenchymal stromal cells (MSC) intravenous infusion at least two fix |
Completed |
Study Name: Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease Condition: Graft vs Host Disease Date: 2010-01-04 Interventions: Drug: Alemtuzumab and rituximab Alemtuzumab at 10mg subcutaneously daily for 3 doses (days 1, 2 and 3) R |
Completed |
Study Name: CC-4047 (Pomalidomide) for Graft vs. Host Disease Condition: Graft vs Host Disease Date: 2008-10-07 Interventions: Drug: CC-4047 Other Name: Pomalidomide |
Recruiting |
Study Name: A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2008-09-25 Interventions: Drug: Imatinib |
Terminated |
Study Name: Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease Condition: Graft vs Host Disease Date: 2008-03-04 |
Recruiting |
Study Name: Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease Condition: Graft vs Host Disease Date: 2006-10-20 Interventions: Drug: Topical Dexamethasone Drug: Placebo |
Completed |
Study Name: Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease Condition: Graft vs Host Disease Date: 2006-10-12 Interventions: Drug: Sirolimus Patients will |